Phospholipase A 2 structure/function, mechanism, and signaling

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Burke, John E ^a,b   Dennis, Edward A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego   (United States)

Author keywords

Arachidonic acid; Lipid signaling; Phospholipids

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CALCIUM; PHOSPHOLIPASE A2;

ANIMAL; CHEMISTRY; CYTOSOL; ENZYMOLOGY; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; REVIEW; SECRETION; SIGNAL TRANSDUCTION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; CALCIUM; CYTOSOL; HUMANS; LIPID METABOLISM; PHOSPHOLIPASES A2; SIGNAL TRANSDUCTION;

EID: 66349090778     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800033-JLR200     Document Type: Review

References (63)

1. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294: 1871-1875. (Pubitemid 33101574)
2. Rivera, R., and J. Chun. 2008. Biological effects of lysophospholipids. Rev. Physiol. Biochem. Pharmacol. 160: 25-46.
3. Stephens, W. W., J. L. Walker, and W. Myers. 1898. The action of cobra poison on the blood: a contribution to the study of passive immunity. J. Pathol. Bacteriol. 5: 279-301.
4. Seilhamer, J. J., W. Pruzanski, P. Vadas, S. Plant, J. A. Miller, J. Kloss, and L. K. Johnson. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264: 5335-5338. (Pubitemid 19097981)
5. Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, and R. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264: 5768-5775. (Pubitemid 19098041)
6. Kuchler, K., M. Gmachl, M. J. Sippl, and G. Kreil. 1989. Analysis of the Cdna for phospholipase-A2 from honeybee venom glands - the deduced amino-acid sequence reveals homology to the corresponding vertebrate enzymes. Eur. J. Biochem. 184: 249-254.
7. Clark, J. D., L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, and J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 65: 1043-1051. (Pubitemid 121001692)
8. Kramer, R. M., E. F. Roberts, J. Manetta, and J. E. Putnam. 1991. The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266: 5268-5272. (Pubitemid 21909485)
9. Dennis, E. A. 1994. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269: 13057-13060. (Pubitemid 24206060)
10. Chen, J., S. J. Engle, J. J. Seilhamer, and J. A. Tischfield. 1994. Cloning and recombinant expression of a novel human low-molecular-weight Ca2+-dependent phospholipase-a(2). J. Biol. Chem. 269: 2365-2368.
11. Balboa, M. A., J. Balsinde, M. V. Winstead, J. A. Tischfield, and E. A. Dennis. 1996. Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J. Biol. Chem. 271: 32381-32384. (Pubitemid 26422280)
12. Ackermann, E. J., E. S. Kempner, and E. A. Dennis. 1994. Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J. Biol. Chem. 269: 9227-9233.
13. Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
14. Schaloske, R. H., and E. A. Dennis. 2006. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta. 1761: 1246-1259. (Pubitemid 44755364)
15. Scott, D. L., S. P. White, Z. Otwinowski, W. Yuan, M. H. Gelb, and P. B. Sigler. 1990. Interfacial catalysis: the mechanism of phospholipase A2. Science. 250: 1541-1546.
16. Yu, L., and E. A. Dennis. 1991. Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues. Proc. Natl. Acad. Sci. USA. 88: 9325-9329. (Pubitemid 21915624)
17. Gelb, M. H., M. K. Jain, A. M. Hanel, and O. G. Berg. 1995. Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. Annu. Rev. Biochem. 64: 653-688.
18. Carman, G. M., R. A. Deems, and E. A. Dennis. 1995. Lipid signaling enzymes and surface dilution kinetics. J. Biol. Chem. 270: 18711-18714.
19. Plesniak, L. A., L. Yu, and E. A. Dennis. 1995. Conformation of micellar phospholipid bound to the active site of phospholipase A2. Biochemistry. 34: 4943-4951.
20. Burke, J. E., M. J. Karbarz, R. A. Deems, S. Li, V. L. Woods, Jr., and E. A. Dennis. 2008. Interaction of group IA phospholipase A2 with metal ions and phospholipid vesicles probed with deuterium exchange mass spectrometry. Biochemistry. 47: 6451-6459. (Pubitemid 351874236)
21. Lin, Y., R. Nielsen, D. Murray, W. L. Hubbell, C. Mailer, B. H. Robinson, and M. H. Gelb. 1998. Docking phospholipase A2 on membranes using electrostatic potential-modulated spin relaxation magnetic resonance. Science. 279: 1925-1929. (Pubitemid 28168646)
22. Singer, A. G., F. Ghomashchi, C. Le Calvez, J. Bollinger, S. Bezzine, M. Rouault, M. Sadilek, E. Nguyen, M. Lazdunski, G. Lambeau, et al. 2002. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J. Biol. Chem. 277: 48535-48549. (Pubitemid 35470814)
23. Lambeau, G., and M. H. Gelb. 2008. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu. Rev. Biochem. 77: 495-520.
24. Schevitz, R. W., N. J. Bach, D. G. Carlson, N. Y. Chirgadze, D. K. Clawson, R. D. Dillard, S. E. Draheim, L. W. Hartley, N. D. Jones, E. D. Mihelich, et al. 1995. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat. Struct. Biol. 2: 458-465.
25. Lambeau, G., and M. Lazdunski. 1999. Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol. Sci. 20: 162-170.
26. Saegusa, J., N. Akakura, C. Y. Wu, C. Hoogland, Z. Ma, K. S. Lam, F. T. Liu, Y. K. Takada, and Y. Takada. 2008. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins {alpha}v{beta}3 and {alpha}4{beta}1 and induces proliferation of monocytic cells in an integrin-dependent manner. J. Biol. Chem. 283: 26107-26115.
27. Kramer, R. M., G. C. Checani, A. Deykin, C. R. Pritzker, and D. Deykin. 1986. Solubilization and properties of Ca2+-dependent human platelet phospholipase A2. Biochim. Biophys. Acta. 878: 394-403. (Pubitemid 16033314)
28. Ghosh, M., D. E. Tucker, S. A. Burchett, and C. C. Leslie. 2006. Properties of the group IV phospholipase A2 family. Prog. Lipid Res. 45: 487-510.
29. 2. Biochim. Biophys. Acta. 1167: 272-280.
30. Bonventre, J. V., Z. Huang, M. R. Taheri, E. O'Leary, E. Li, M. A. Moskowitz, and A. Sapirstein. 1997. Reduced fertility and post-ischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390: 622-625. (Pubitemid 28016198)
31. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, et al. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390: 618-622. (Pubitemid 28016197)
32. Uozumi, N., and T. Shimizu. 2002. Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice. Prostaglandins Other Lipid Mediat. 68-69: 59-69. (Pubitemid 35247387)
33. Dessen, A., J. Tang, H. Schmidt, M. Stahl, J. D. Clark, J. Seehra, and W. S. Somers. 1999. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell. 97: 349-360. (Pubitemid 29214591)
34. Hsu, Y. H., J. E. Burke, D. L. Stephens, R. A. Deems, S. Li, K. M. Asmus, V. L. Woods, Jr., and E. A. Dennis. 2008. Calcium binding rigidifies the C2 domain and the intra-domain interaction of GIVA phospholipase A2 as revealed by hydrogen/deuterium exchange mass spectrometry. J. Biol. Chem. 283: 9820-9827.
35. Burke, J. E., Y. H. Hsu, R. A. Deems, S. Li, V. L. Woods, Jr., and E. A. Dennis. 2008. A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2. J. Biol Chem 283: 31227-31236.
36. Stahelin, R. V., P. Subramanian, M. Vora, W. Cho, and C. E. Chalfant. 2007. Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain. J. Biol. Chem. 282: 20467-20474. (Pubitemid 47100015)
37. Six, D. A., and E. A. Dennis. 2003. Essential Ca(2+)-independent role of the group IVA cytosolic phospholipase A(2) C2 domain for interfacial activity. J. Biol. Chem. 278: 23842-23850. (Pubitemid 36830210)
38. Burke, J. E., and E. A. Dennis. 2008. Phospholipase A2 biochemistry. Cardiovasc. Drugs Ther. In press.
39. Six, D. A., E. Barbayianni, V. Loukas, V. Constantinou-Kokotou, D. Hadjipavlou-Litina, D. Stephens, A. C. Wong, V. Magrioti, P. Moutevelis-Minakakis, S. F. Baker, et al. 2007. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A(2) and group v secreted phospholipase A(2). J. Med. Chem. 50: 4222-4235. (Pubitemid 47301753)
40. McKew, J. C., K. L. Lee, M. W. Shen, P. Thakker, M. A. Foley, M. L. Behnke, B. Hu, F. W. Sum, S. Tam, Y. Hu, et al. 2008. Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl) sulfonyl]amino}ethyl)-1-(dipheny lmethyl)-1H-indol-3-yl]propyl} benzoic acid, efipladib. J. Med. Chem. 51: 3388-3413. (Pubitemid 351874997)
41. Yaksh, T. L., G. Kokotos, C. I. Svensson, D. Stephens, C. G. Kokotos, B. Fitzsimmons, D. Hadjipavlou-Litina, X. Y. Hua, and E. A. Dennis. 2006. Systemic and intrathecal effects of a novel series of phospholipase A(2) inhibitors on hyperalgesia and spinal prostaglandin E-2 release. J. Pharmacol. Exp. Ther. 316: 466-475. (Pubitemid 41832627)
42. Adler, D. H., J. D. Cogan, J. A. Phillips 3rd, N. Schnetz-Boutaud, G. L. Milne, T. Iverson, J. A. Stein, D. A. Brenner, J. D. Morrow, O. Boutaud, et al. 2008. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J. Clin. Invest. 118: 2121-2131. (Pubitemid 351872331)
43. Balboa, M. A., J. Balsinde, S. S. Jones, and E. A. Dennis. 1997. Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J. Biol. Chem. 272: 8576-8580. (Pubitemid 27147823)
44. Winstead, M. V., J. Balsinde, and E. A. Dennis. 2000. Calcium-independent phospholipase A(2): structure and function. Biochim. Biophys. Acta. 1488: 28-39.
45. Song, H., S. Ramanadham, S. Bao, F. F. Hsu, and J. Turk. 2006. A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols. Biochemistry. 45: 1061-1073. (Pubitemid 43124112)
46. Balsinde, J., and M. A. Balboa. 2005. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A(2) in activated cells. Cell. Signal. 17: 1052-1062. (Pubitemid 40933526)
47. Bao, S., D. J. Miller, Z. Ma, M. Wohltmann, G. Eng, S. Ramanadham, K. Moley, and J. Turk. 2004. Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility. J. Biol. Chem. 279: 38194-38200. (Pubitemid 39295966)
48. Bao, S., H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk. 2006. Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J. Biol. Chem. 281: 20958-20973. (Pubitemid 44115437)
49. Bao, S., Y. Li, X. Lei, M. Wohltmann, W. Jin, A. Bohrer, C. F. Semenkovich, S. Ramanadham, I. Tabas, and J. Turk. 2007. Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2. J. Biol. Chem. 282: 27100-27114. (Pubitemid 47501970)
50. Ramanadham, S., K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk. 2008. Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice. Am. J. Pathol. 172: 868-881. (Pubitemid 351519985)
51. Baskakis, C., V. Magrioti, N. Cotton, D. Stephens, V. Constantinou-Kokotou, E. A. Dennis, and G. Kokotos. 2008. Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes. J. Med. Chem. 51(24): 8027-8037.
52. Lopez-Vales, R., X. Navarro, T. Shimizu, C. Baskakis, G. Kokotos, V. Constantinou-Kokotou, D. Stephens, E. A. Dennis, and S. David. 2008. Intracellular phospholipase A2 group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain.
53. Mishra, R. S., K. A. Carnevale, and M. K. Cathcart. 2008. iPLA2beta: front and center in human monocyte chemotaxis to MCP-1. J. Exp. Med. 205: 347-359. (Pubitemid 351281601)
54. Gelb, M. H., J. H. Min, and M. K. Jain. 2000. Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes. Biochim. Biophys. Acta. 1488: 20-27.
55. Tjoelker, L. W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270: 25481-25487.
56. Gardner, A. A., E. C. Reichert, M. K. Topham, and D. M. Stafforini. 2008. Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein. J. Biol. Chem. 283: 17099-17106.
57. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L. S. Cousens, G. A. Zimmerman, et al. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374: 549-553.
58. Lavi, S., J. Herrmann, R. Lavi, J. P. McConnell, L. O. Lerman, and A. Lerman. 2008. Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Curr. Atheroscler. Rep. 10: 230-235.
59. Lerman, A., and J. P. McConnell. 2008. Lipoprotein-associated phospholipase A2: a risk marker or a risk factor? Am. J. Cardiol. 101: 11F-22F.
60. Blackie, J. A., J. C. Bloomer, M. J. Brown, H. Y. Cheng, B. Hammond, D. M. Hickey, R. J. Ife, C. A. Leach, V. A. Lewis, C. H. Macphee, et al. 2003. The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorg. Med. Chem. Lett. 13: 1067-1070. (Pubitemid 36331801)
61. Serruys, P. W., H. M. Garcia-Garcia, P. Buszman, P. Erne, S. Verheye, M. Aschermann, H. Duckers, O. Bleie, D. Dudek, H. E. Botker, et al. 2008. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation. 118: 1172-1182.
62. Mohler 3rd, E. R., C. M. Ballantyne, M. H. Davidson, M. Hanefeld, L. M. Ruilope, J. L. Johnson, and A. Zalewski. 2008. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. 51: 1632-1641. (Pubitemid 351635837)
63. Wilensky, R. L., Y. Shi, E. R. Mohler 3rd, D. Hamamdzic, M. E. Burgert, J. Li, A. Postle, R. S. Fenning, J. G. Bollinger, B. E. Hoffman, et al. 2008. Inhibition of lipoprotein-associated phospholipase A(2) reduces complex coronary atherosclerotic plaque development. Nat. Med. In press.